icd10free.comPowered by Curo

ICD-10 Coding for Neuroendocrine Carcinoma(C7A.1, C78.7, E34.0)

Save

Explore detailed ICD-10 coding guidelines for neuroendocrine carcinoma, including differentiation criteria and documentation requirements.

Also known as:
NECNeuroendocrine TumorPoorly Differentiated Neuroendocrine Carcinoma
Related ICD-10 Code Ranges

Complete code families applicable to Neuroendocrine Carcinoma

C00-D49Primary Range

Neoplasms

→
Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
C7A.1Malignant poorly differentiated neuroendocrine tumors
C7A.8Other malignant neuroendocrine tumors
C7B.0Secondary neuroendocrine tumors
Primary ICD-10-CM Codes
Malignant poorly differentiated neuroendocrine tumors
C7A.1Billable

Documentation & Coding Risks

Avoid these common issues when documenting Neuroendocrine Carcinoma.

Omitting Ki-67 index in documentation

Impact

Clinical: Inaccurate treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.

Mitigation

Ensure pathology reports include Ki-67 index., Educate clinicians on documentation requirements.

Confusing NEC with NET terms

Impact

Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with coding standards., Data Quality: Inaccurate clinical data.

Mitigation

Ensure differentiation is documented and coded correctly.

Differentiation Documentation

Impact

Lack of differentiation details can lead to coding errors.

Mitigation

Implement mandatory documentation checks for differentiation.

Frequently Asked Questions

Related condition guides

Documentation requirements, coding pitfalls and FAQs for conditions coded with C7A.1.